Lumin Health Cambridge, Massachusetts | Insurance-Covered Ketamine Therapy for Depression, Anxiety and PTSD
50 Church Street, 3rd floor, Cambridge
5.0(19 Google reviews)
United States
3 listed treatment centers serving Cambridge and the surrounding area.
50 Church Street, 3rd floor, Cambridge
5.0(19 Google reviews)
625 Mount Auburn Street, Suite 205A, Cambridge
4.1(18 Google reviews)
625 Mount Auburn Street, Suite 205A, Cambridge
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Cambridge.
4.1 miles away · Newton
313 Washington Street, 310, Newton
4.8(6 Google reviews)
For people in Cambridge considering SPRAVATO®, costs depend on insurance benefits, the treatment setting, and the services billed. The medication and the supervised treatment and monitoring visit may generate separate charges. Ask for an explanation of both rather than assuming a medication benefit covers the entire appointment.
Prior authorization is common. Your insurer may require records of earlier antidepressant trials, including which medications you tried and how you responded. Ask your prescribing clinician and treatment center who will gather those records, submit the request, and follow up if more information is needed. Authorization does not necessarily mean every charge is fully covered.
Medicare coverage may fall under Part B or Part D, depending on the plan and setting. Massachusetts Medicaid coverage also depends on the applicable plan and treatment arrangements. Confirm benefits directly with your insurer and ask whether the center accepts your coverage for both the medication and visit services.
Manufacturer savings programs exist for eligible commercially insured patients, but not for patients using government insurance. Eligibility rules apply; ask the center to help you review current terms without assuming you qualify.
Before starting, ask the center and insurer:
Request a written estimate when available, while recognizing that estimates are not coverage guarantees.
SPRAVATO® treatment requires repeated visits to a REMS-certified healthcare setting. You administer the nasal spray yourself under a healthcare provider’s direct observation; it is never sent home for use between appointments.
This directory currently has no listed treatment center in Cambridge. It also provides no other Massachusetts cities with listed centers to suggest nearby. That is a directory limitation, not proof that treatment is unavailable locally. Ask your prescribing clinician or insurer for help locating a center, then confirm directly that the location is REMS-certified and accepting patients before making arrangements.
The typical labeled schedule begins with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber will determine the schedule appropriate for you rather than promise a fixed course.
Plan for at least two hours of monitoring after each dose, plus time for check-in, preparation, and discharge assessment. Ask the center how much time to reserve overall. Discuss recurring time off or schedule changes with your employer, and arrange help with caregiving responsibilities if needed.
You need someone else to drive you home. You must not drive or operate machinery until the next day after a restful sleep. Arrange rides before booking, identify a backup driver, and ask the center about its pickup and escort requirements. If transportation becomes unavailable, contact the center rather than planning to drive yourself. Build the ride home and recovery time into your treatment-day plans.
This directory currently has no listed center in Cambridge and no other listed Massachusetts cities to point you toward. Ask your prescribing clinician or insurer for help finding a treatment location. Before scheduling, confirm that the specific location is SPRAVATO® REMS-certified, accepts new patients, and can provide the required monitoring. Offering treatment alone does not establish certification.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved, together with an oral antidepressant, for depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior. It is not approved for children. A clinician must review your diagnosis, treatment history, and safety considerations before deciding whether it is appropriate.
Coverage depends on your plan and the treatment setting, including for Medicare and Massachusetts Medicaid. Prior authorization and documentation of earlier antidepressant trials are common requirements. Ask whether both the medication and monitoring services are covered, whether the location is in network, and what you might owe. A center’s acceptance of your insurance does not guarantee authorization or payment for every service.
You self-administer the nasal spray in a REMS-certified healthcare setting under direct observation. Staff monitor you for at least two hours after the dose, including for sedation, dissociation, breathing problems, and blood pressure increases. Ask how much additional time to allow for preparation and discharge assessment. You cannot take doses home, and someone else must drive you home after treatment.
Important risks include sedation, dissociation, respiratory depression, and increased blood pressure. Dissociation can feel like being disconnected from yourself or your surroundings. Boxed warnings also address abuse and misuse and suicidal thoughts and behaviors. Spravato is a Schedule III controlled substance. Discuss your medical history, medications, and substance use history openly so your clinician can assess risks and explain monitoring.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when needed. Do not wait for a treatment appointment during a crisis. Call or text 988 for crisis support, or call 911 if you are in immediate danger or need emergency medical help.
Approved uses, nearby treatment centers, and medically sourced patient guides.